Clinical Trials Directory

Trials / Completed

CompletedNCT01384396

A Clinical Study of KW-3357 in Patients With DIC

A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by the Diagnostic Criteria for DIC Established by the Japanese Ministry of Health and Welfare

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Kyowa Kirin Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by the diagnostic criteria for DIC established by the Japanese Ministry of Health and Welfare.

Conditions

Interventions

TypeNameDescription
DRUGKW-3357Intravenous infusion once a day

Timeline

Start date
2011-12-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2011-06-29
Last updated
2017-03-24

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01384396. Inclusion in this directory is not an endorsement.

A Clinical Study of KW-3357 in Patients With DIC (NCT01384396) · Clinical Trials Directory